Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Midis mission is to revolutionize healthcare for women at midlife, wherever they live and whatever their health story
The FDA warns that both CJC-1295 and ipamorelin are risky for immunogenicity, potentially causing life-threatening outcomes such as anaphylaxis.25 26 Cardiovascular concerns: Specifically concerning CJC-1295, the FDA warns of the risk of increased heart rate and systemic vasodilatory reaction, including flushing, warmth, and transient hypotension.25 27 Cancer: With their ability to increase the rate of cellular replication, growth hormone secretagogues in general are unsafe for cancer survivors and people with an active cancer diagnosis.28 Secretagogue use may elevate their risk for recurrence or worsen their prognosis
The Enforcement Environment Is Getting Harsher, Not Easier RFK Jr
Magazines and newsletters
Well explain how B12 therapy works in plain language, not medical terms
What safe access looks like A genuine clinical consultation before any prescription
